移植后免疫抑制疗法与哺乳的兼容性
Gema Gomez-Casado1,2, Juana Alonso-Titos1,3, Ernesto Gonzalez-Mesa1,4,5
1Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma BIONAND, University of Malaga, 29010 Malaga, Spain.
Journal of clinical medicine
|April 12, 2025
概括
移植脏后的母乳养可能是安全的,因为像环素和塔克罗利斯这样的免疫抑制剂显示最小的转移到母乳中. 需要进一步的长期研究来确认婴儿的安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 哺乳期医学 哺乳期医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 接受移植的接受者有更高的早产和低出生体重婴儿的风险.
- 哺乳提供了显著的好处,特别是对于早产婴儿.
- 对通过母乳传递免疫抑制剂的担忧,历来限制了母乳养建议.
研究的目的:
- 对母乳养母亲进行移植后使用的免疫抑制药物的安全性和药理动力学进行审查.
- 评估常见免疫抑制剂与哺乳期的兼容性.
- 为了为临床决策提供有关养后脏移植的信息.
主要方法:
- 对当前免疫抑制药物 (环素,塔克罗利斯,埃弗罗利斯,阿扎西奥普林,皮质类固醇,贝拉塔塞普特) 的文献进行系统审查.
- 分析药理动力学数据和报告的婴儿结局.
- 检查药物转移到母乳中的情况.
主要成果:
- 已发表的数据表明,研究的免疫抑制剂的转移到母乳中是最小的,并且被认为对婴儿健康是安全的.
- 短期测量和小患者数量限制了最终的结论.
- 在经过审查的文献中,没有报告与药物转移直接相关的不良事件.
结论:
- 目前的证据表明,在移植后服用某些免疫抑制剂时,母乳养可能是安全的.
- 长期的前性研究对于建立最终的安全概况至关重要.
- 临床医生需要最新的证据来指导为母乳养的脏移植接受者提供个性化建议.
相关概念视频
Cell-mediated Immune Responses
66.1K
Overview
66.1K
Tissue Transplantation
280
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
280
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37


